Camping World Holdings Inc (CWH) Q4 2025 Earnings Call Transcript

Why It Matters

The shift toward diversified, higher‑margin end markets reduces CTS’s reliance on a weakening transportation segment and underpins sustainable earnings growth.

Key Takeaways

• Revenue $137M, +9% YoY, flat sequentially.
• Diversified markets 59% of revenue, 16% YoY growth.
• Medical sales +41% Q4, +21% full year.
• Adjusted gross margin 39.1%, up 150 basis points.
• 2026 guidance: $550‑$580M sales, EPS $2.30‑$2.45.

Pulse Analysis

CTS’s fourth‑quarter results highlight a pivotal transition from a transportation‑centric business model to a broader, sensor‑driven portfolio. Revenue growth outpaced the automotive slowdown, and the diversified segment now accounts for nearly 60% of sales, reflecting successful execution of the company’s strategic pivot. Higher‑margin medical and industrial applications not only lifted overall profitability but also insulated earnings from cyclical pressures in the commercial vehicle market, a trend echoed across the broader industrial sensing sector.

The medical end market emerged as a standout growth engine, posting a 41% quarterly surge and a 21% annual increase. This acceleration is fueled by rising demand for minimally invasive diagnostics and therapeutic devices, where CTS’s precision sensors enhance imaging accuracy and treatment delivery. Simultaneously, the industrial segment benefited from automation and energy‑efficiency trends, delivering a 16% quarterly sales jump. These dynamics align with macro‑level shifts toward smarter manufacturing and healthcare digitization, positioning CTS to capture expanding addressable markets.

Looking ahead, the company’s 2026 outlook—$550‑$580 million in sales and EPS of $2.30‑$2.45—rests on continued diversification, a robust $1 billion transportation backlog, and anticipated normalization of defense funding. While transportation volumes may remain flat, strategic M&A and product innovations such as powertrain‑agnostic actuators and e‑brake solutions provide upside potential. Investors should view CTS’s balanced capital allocation, strong cash flow, and expanding high‑margin segments as indicators of resilient, long‑term value creation.